Haemonetics gets FDA warning regarding production issues

12/23/2008 | Reuters

The FDA has sent a warning letter to Haemonetics that alleges manufacturing problems at its Illinois facility, including the lack of quality-control procedures for its blood-collection devices. The agency gave the firm 15 days to respond. Company officials were not immediately available for comment.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care